Wells Fargo’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$653K Buy
80,721
+1,002
+1% +$8.11K ﹤0.01% 3612
2025
Q1
$668K Buy
79,719
+1,746
+2% +$14.6K ﹤0.01% 3487
2024
Q4
$618K Sell
77,973
-99,862
-56% -$791K ﹤0.01% 3586
2024
Q3
$1.48M Buy
177,835
+118,490
+200% +$986K ﹤0.01% 2968
2024
Q2
$377K Buy
59,345
+10,867
+22% +$69K ﹤0.01% 3746
2024
Q1
$294K Buy
48,478
+10,362
+27% +$62.8K ﹤0.01% 3881
2023
Q4
$231K Buy
38,116
+6,872
+22% +$41.7K ﹤0.01% 4002
2023
Q3
$132K Sell
31,244
-25,262
-45% -$107K ﹤0.01% 4287
2023
Q2
$175K Buy
56,506
+34,416
+156% +$107K ﹤0.01% 4418
2023
Q1
$30.7K Buy
22,090
+20,879
+1,724% +$29K ﹤0.01% 5133
2022
Q4
$2.41K Sell
1,211
-12,651
-91% -$25.2K ﹤0.01% 5639
2022
Q3
$28K Sell
13,862
-1,122
-7% -$2.27K ﹤0.01% 4905
2022
Q2
$48K Sell
14,984
-221,818
-94% -$711K ﹤0.01% 4764
2022
Q1
$988K Sell
236,802
-151,101
-39% -$630K ﹤0.01% 3668
2021
Q4
$1.86M Sell
387,903
-366,788
-49% -$1.76M ﹤0.01% 3359
2021
Q3
$4.03M Sell
754,691
-119,913
-14% -$640K ﹤0.01% 2896
2021
Q2
$4.48M Buy
874,604
+40,822
+5% +$209K ﹤0.01% 2848
2021
Q1
$5.61M Buy
833,782
+497,351
+148% +$3.35M ﹤0.01% 2610
2020
Q4
$1.54M Sell
336,431
-35,692
-10% -$163K ﹤0.01% 3631
2020
Q3
$1.45M Buy
372,123
+63,124
+20% +$245K ﹤0.01% 3514
2020
Q2
$1.47M Buy
308,999
+94,673
+44% +$450K ﹤0.01% 3449
2020
Q1
$746K Sell
214,326
-386,559
-64% -$1.35M ﹤0.01% 3637
2019
Q4
$2.9M Sell
600,885
-321,020
-35% -$1.55M ﹤0.01% 3007
2019
Q3
$2.67M Buy
921,905
+734,549
+392% +$2.13M ﹤0.01% 3047
2019
Q2
$1.34M Sell
187,356
-183,313
-49% -$1.31M ﹤0.01% 3612
2019
Q1
$5.25M Buy
370,669
+44,154
+14% +$626K ﹤0.01% 2496
2018
Q4
$4.42M Buy
326,515
+26,167
+9% +$354K ﹤0.01% 2520
2018
Q3
$6.67M Buy
300,348
+13,037
+5% +$289K ﹤0.01% 2394
2018
Q2
$4.72M Buy
+287,311
New +$4.72M ﹤0.01% 2720